0

Your Cart is Empty

Sodium Chloride Injection 0.9% USP, 100 mL

B. Braun

S8004-5264

Shipping Type: Small Supplies | See Shipping Policy for more details

0.9% Sodium Chloride Injection USP (Saline) 100mL Fill in 150 mL is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion.

Not made with natural rubber latex, PVC or DEHP.

Specific Gravity: 1.006

NDC Number: 00264180032

Comes in a Case of 64 Bags

Product Identification:


Storage and Shipping

Total Shelf Life (Months) 030
Ordering Unit Case
Units per Case 64

B. Braun Medical Inc. is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Their purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients.

See video on spiking the Excel IV Bag for more info

Each 100 mL of 0.9% Sodium Chloride Injection USP contains:

Sodium Chloride USP 0.9 g; Water for Injection USP qs
pH: 5.6 (4.5–7.0) Calculated Osmolarity: 308 mOsmol/liter
pH adjusted with Hydrochloric Acid NF
Concentration of Electrolytes (mEq/liter): Sodium 154 Chloride 154

Each 100 mL of 0.45% Sodium Chloride Injection USP contains:

Sodium Chloride USP 0.45 g; Water for Injection USP qs
pH: 5.6 (4.5–7.0) Calculated Osmolarity: 154 mOsmol/liter, hypotonic
pH adjusted with Hydrochloric Acid NF
Concentration of Electrolytes (mEq/liter): Sodium 77 Chloride 77

Sodium Chloride Injections USP are sterile, nonpyrogenic, isotonic and contain no bacteriostatic or antimicrobial agents.

The formula of the active ingredient is:

Ingredient Molecular Formula Molecular Weight
Sodium Chloride USP NaCl 58.44
Not made with natural rubber latex, PVC or DEHP.

The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.

Addition of medication should be accomplished using complete aseptic technique.

The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication addition site. Refer to the Directions for Use of the container.

Product Identification:


Storage and Shipping

Total Shelf Life (Months) 030
Ordering Unit Case
Units per Case 64

B. Braun Medical Inc. is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Their purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients.

See video on spiking the Excel IV Bag for more info

Each 100 mL of 0.9% Sodium Chloride Injection USP contains:

Sodium Chloride USP 0.9 g; Water for Injection USP qs
pH: 5.6 (4.5–7.0) Calculated Osmolarity: 308 mOsmol/liter
pH adjusted with Hydrochloric Acid NF
Concentration of Electrolytes (mEq/liter): Sodium 154 Chloride 154

Each 100 mL of 0.45% Sodium Chloride Injection USP contains:

Sodium Chloride USP 0.45 g; Water for Injection USP qs
pH: 5.6 (4.5–7.0) Calculated Osmolarity: 154 mOsmol/liter, hypotonic
pH adjusted with Hydrochloric Acid NF
Concentration of Electrolytes (mEq/liter): Sodium 77 Chloride 77

Sodium Chloride Injections USP are sterile, nonpyrogenic, isotonic and contain no bacteriostatic or antimicrobial agents.

The formula of the active ingredient is:

Ingredient Molecular Formula Molecular Weight
Sodium Chloride USP NaCl 58.44
Not made with natural rubber latex, PVC or DEHP.

The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.

Addition of medication should be accomplished using complete aseptic technique.

The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication addition site. Refer to the Directions for Use of the container.


Questions & Answers

Have a Question?

Be the first to ask a question about this.

Ask a Question